5.3.3 Diagnostics Moves Out of the Hospital
5.3.4 Disruption Looms
6 PCR Recent Developments
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Bio Molecular Systems Gets Approval for Portable PCR Cycler
6.3 Roche Acquires GenMark
6.5 Nuclein Closes $14M in Funding
6.6 WuXi Diagnostics Closes $150M Series B Financing Round
6.7 Visby Medical to develop rapid Flu-COVID PCR test
6.8 Thermo Fisher to acquire Mesa Biotech
6.9 Scope Fluidics Secures €6.2M Supporting Rapid MDx
6.10 SARS- Testing Demand to Continue Through 2022, and Beyond
6.11 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
6.12 Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
6.13 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
6.14 HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform